PARATEK PHARMACEUTICALS, INC. PRTK Cash Flow

Paratek pharmaceuticals, inc. (PRTK)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Net loss
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-111,458	-100,699	-89,149	-89,069	-93,630	-95,934	-108,035	-111,636	-106,288	-106,082	-91,498	-70,860	-60,875	-40,686	-27,257	-17,835	10,544	9,074	4,636	-4,653	-28,465	-18,907	-17,339	-12,016	-166	-10,012	-7,118	-3,880	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization and accretion
-737	-1,292	-1,660	-2,249	-1,738	-1,066	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	2,375	2,360	2,303	1,111	903	686	714	740	580	462	196	16	36	63	98	129	172	204	229	249	270	309	357	0	0	0
Stock-based compensation expense
12,967	14,295	23,279	23,540	24,988	25,492	16,839	16,836	17,225	16,902	15,708	14,285	12,417	10,792	10,224	9,078	7,240	5,062	3,139	1,815	932	706	-1,583	-981	-546	249	3,069	3,018	2,966	2,929	4,567	4,506	4,435	4,405	0	0	0
Noncash interest expense
5,274	3,480	3,281	2,557	5,101	2,792	4,660	1,997	552	406	-177	-29	177	241	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncash interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncash interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,860	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in fair value of contingent consideration
-	-	-	-	-	-71	-70	-81	-368	-584	-866	-1,014	-681	-345	-630	-700	-315	-3,560	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss (gain) on mark-to-market on convertible notes and preferred stock warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Other gains, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of lease liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-191	-248	-291	-274	-316	0	0	0
Gain on disposals of fixed assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25	17	-1	0	0	0	0	-	-	-	-
Amortization of premium on available for sale securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-736	-573	-493	-561	-672	-823	-1,040	-1,250	0	0	0
Changes in operating assets and liabilities
Accounts receivable and other current assets
0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of prepaid interest - marketable securities
0	-	-	-	-	715	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventories
9,614	10,856	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease right-of-use asset
-740	-721	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
-5,608	374	-3,962	-2,529	-965	-641	6,035	955	-3,236	-4,223	-4,506	-11,274	-5,807	2,062	5,971	13,898	15,908	14,021	5,447	7,356	-391	-6,401	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease liability
-984	-1,718	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities and other assets
-1,321	-1,208	-873	-933	-623	-839	-724	-756	-725	-816	1,239	1,836	2,046	2,475	648	330	560	779	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-7,292	0	0	0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-100,515	-94,098	-85,559	-78,277	-69,884	-54,682	-49,389	-29,989	-18,182	-18,533	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid and other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	980	610	1,770	6,211	1,312	1,668	468	2,023	0	0	0
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	795	-636	-15	14	453	-179	209	389	0	0	0
Accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,099	-1,111	-379	-558	1,145	724	300	631	0	0	0
Net cash used in operating activities
-128,615	-134,045	-117,500	-109,802	-97,883	-81,179	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-22,883	-14,575	-15,928	-15,205	5,752	-6,059	-4,962	-5,707	0	0	0
Investing activities
Purchase of fixed assets
481	239	51	17	47	60	6	43	244	1,117	1,541	1,444	1,488	690	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of fixed assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21	33	43	43	51	31	50	59	0	0	0
Proceeds from Sale of Property and Equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Purchase of marketable securities
0	-	-	-	-	292,864	251,665	307,134	202,316	180,289	191,905	161,477	95,111	135,799	0	0	0	-	-	-	-	-	-	-	-	-	92,429	82,361	58,049	41,037	26,320	29,877	46,762	52,175	0	0	0
Proceeds from maturities of marketable securities
230,000	237,000	252,992	239,250	204,050	165,050	153,558	158,550	137,250	131,250	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by investing activities
107,681	134,554	103,732	144,791	-39,169	-127,874	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-34,188	-17,091	4,988	5,170	20,629	10,592	1,688	1,266	0	0	0
Financing activities
Proceeds from maturities of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	58,230	65,280	63,080	46,250	47,000	40,500	48,500	53,500	0	0	0
Increase (decrease) in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-8,920	-74,757	-69,923	-64,728	-69,948	-603	13,186	13,090	13,600	13,667	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of non-convertible note
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	286	82,761	82,951	82,949	82,795	321	20	22	11	13	24	242	247	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of common stock, net of costs
0	-	-	-	-	51,517	0	0	0	-	91,745	88,003	107,050	70,930	0	0	0	-	-	-	-	-	-	-	-	-	676	519	38,329	38,744	39,600	39,563	1,986	1,380	0	0	0
Net cash provided by financing activities
0	-	-	-	-	220,727	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	676	519	38,329	38,744	39,600	39,563	1,986	1,380	0	0	0
Net increase in cash, cash equivalents and restricted cash
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Refund of financing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	126,646	90,515	61,992	81,690	91,465	90,731	181,097	165,530	95,589	99,510	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net increase in cash, cash equivalents and restricted cash
-	-	-	-	-	-	56,226	4,645	-12,669	-18,201	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-78,340	-93,490	-61,315	-48,367	35,446	0	0	0	-	-	-	-	196	-56,395	-31,147	27,389	28,709	65,981	44,096	-1,288	-3,061	0	0	0
Net increase (decrease) in cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest
16,952	15,960	15,138	13,962	9,704	9,310	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of equipment included in accrued expenses
0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-